195 related articles for article (PubMed ID: 21885990)
1. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
Liuni A; Luca MC; Gori T; Parker JD
J Am Coll Cardiol; 2010 Mar; 55(10):1002-6. PubMed ID: 20202516
[TBL] [Abstract][Full Text] [Related]
3. Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal.
Taneva E; Borucki K; Wiens L; Makarova R; Schmidt-Lucke C; Luley C; Westphal S
Am J Cardiol; 2006 Apr; 97(7):1002-6. PubMed ID: 16563905
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
[TBL] [Abstract][Full Text] [Related]
5. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
7. Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus.
Amudha K; Choy AM; Mustafa MR; Lang CC
Cardiovasc Ther; 2008; 26(4):253-61. PubMed ID: 19035876
[TBL] [Abstract][Full Text] [Related]
8. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on arterial endothelial function in coronary bypass surgery.
Chello M; Goffredo C; Patti G; Candura D; Melfi R; Mastrobuoni S; Di Sciascio G; Covino E
Eur J Cardiothorac Surg; 2005 Dec; 28(6):805-10. PubMed ID: 16274999
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.
Rawlings R; Nohria A; Liu PY; Donnelly J; Creager MA; Ganz P; Selwyn A; Liao JK
Am J Cardiol; 2009 Feb; 103(4):437-41. PubMed ID: 19195498
[TBL] [Abstract][Full Text] [Related]
11. Statin loading before percutaneous coronary intervention: proposed mechanisms and applications.
Nusca A; Melfi R; Patti G; Sciascio GD
Future Cardiol; 2010 Sep; 6(5):579-89. PubMed ID: 20932108
[TBL] [Abstract][Full Text] [Related]
12. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
13. Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.
Liuni A; Luca MC; Di Stolfo G; Uxa A; Mariani JA; Gori T; Parker JD
J Am Coll Cardiol; 2011 Jan; 57(1):93-8. PubMed ID: 21185507
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.
Dogra G; Irish A; Chan D; Watts G
Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of ecto-5'-nucleotidase by rosuvastatin increases the vasodilator response to ischemia.
Meijer P; Wouters CW; van den Broek PH; de Rooij M; Scheffer GJ; Smits P; Rongen GA
Hypertension; 2010 Oct; 56(4):722-7. PubMed ID: 20679180
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
17. The endothelial-protective effects of HMG-CoA reductase inhibition in the setting of ischemia and reperfusion injury.
Liuni A; Luca MC; Gori T; Parker JD
Clin Hemorheol Microcirc; 2010; 45(2-4):161-7. PubMed ID: 20675896
[TBL] [Abstract][Full Text] [Related]
18. Loss of the preconditioning effect of rosuvastatin during sustained therapy: a human in vivo study.
Liuni A; Luca MC; Gori T; Parker JD
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H153-8. PubMed ID: 22003053
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects.
Vlachopoulos C; Aznaouridis K; Dagre A; Vasiliadou C; Masoura C; Stefanadi E; Skoumas J; Pitsavos C; Stefanadis C
Eur Heart J; 2007 Sep; 28(17):2102-9. PubMed ID: 17597050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]